BCM
XENT

BlueCrest Capital Management’s Intersect ENT, Inc XENT Stock Holding History

BlueCrest Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,864
Closed -$222K – 1193
2015
Q4 		$222K Buy
+9,864
New +$195K 0.01% 815

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlueCrest Capital Management's XENT Position: Q1 2016 in Review

BlueCrest Capital Management sold out of Intersect ENT, Inc (XENT) in Q1 2016, closing a stake of 9,864 shares — an estimated $222K sold.

BlueCrest Capital Management first reported a position in XENT in Q4 2015 and held it in 1 quarter. The position peaked at $222K in Q4 2015. 110 funds tracked by Wall St. Rank hold XENT as of Q1 2016.

  • BlueCrest Capital Management reported no remaining Intersect ENT, Inc position as of Q1 2016 after selling out during the quarter.
  • BlueCrest Capital Management sold 9,864 Intersect ENT, Inc shares in Q1 2016, an estimated $222K.
  • BlueCrest Capital Management first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's Intersect ENT, Inc position peaked at $222K in Q4 2015.
  • 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2016.

Based on BlueCrest Capital Management's 13F filing for Q1 2016, filed 3 May 2016.